Home
Series of Journals
Literature
Latest literature
Popular literature
About us
Intro
Organizational structure
Job Responsibilities
Copyright
Contact us
The title
The title
The keywords
The author
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University
Home
Results
The title
The title
The keywords
The author
A total of
2036
result was found. Results that relate to
M
Practice and reflection of pharmacovigilance system construction
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1217-1224.
9694 times
2360 times
Na WANG
Kang-Huai ZHANG
Phar
m
acovigilance
Drug use safety
Risk prevention and control
Adverse drug reaction
M
edication error
Details
Clinical practice of drug abnormal early warning based on dynamic monitoring of clinical pharmacists
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1225-1230.
7552 times
1929 times
Ting-Ting ZHENG
Jin LI
Lu MAO
Ning CHEN
Wei ZHANG
Jian-Cun ZHEN
Rational drug use
Abnor
m
al early warning
Dyna
m
ic
m
onitoring
Clinical phar
m
acist
Details
Clinical practice guidelines for the use of intravenous polymyxins in children: a protocol
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1231-1237.
6508 times
1700 times
Lin TANG
Shan SHEN
Dong-Na ZOU
Bing LENG
Rui-Fang NIE
Yan JIN
Li-Kai LIN
Xian-Tao ZENG
Suo-Di ZHAI
Ling-Li ZHANG
Ning HOU
Poly
m
yxins
Pediatric
m
edication
Anti-infection
Guideline protocol
Details
A retrospective study on the safety of off-indication use of pyrotinib in patients with non-small cell lung cancer
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1238-1242.
6900 times
1833 times
Hao-Chun TANG
Jun MENG
Zheng-Zheng XIA
Ling-Zhi REN
Non-s
m
all cell lung cancer
Pyrotinib
Adverse drug reaction
Safety
Off-indication
Details
Cost-effectiveness analysis of abemaciclib plus fulvestrant in the second-line treatment for HR﹢/HER2﹣ advanced breast cancer
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1259-1266.
6897 times
1897 times
Xi ZHAO
Xi YAN
Ning LI
Chun-Xia HOU
Abe
m
aciclib
Fulvestrant
Hor
m
one receptor-positive breast cancer
M
arkov
m
odel
Cost-effectiveness analysis
Details
Optimization of extraction process of Coptidis Rhizoma-Scutellariae Radix based on BP-ANN and CCD-RSM in information entropy theory
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1267-1274.
6180 times
1602 times
Bao-Cai WANG
Jun-Jiang LI
Zhi-Wei XU
Coptidis Rhizo
m
a-Scutellariae Radix
BP-ANN
CCD-RS
M
Extraction process
Infor
m
ation entropy theory
Details
Treatment strategy selection for T2DM patients poorly treated with basal insulin combined with oral hypoglycemic agents: umbrella review
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1275-1284.
7421 times
1815 times
Ya-Ping NIU
San-Bao CHAI
Jing-Zi MA
Meng ZHANG
Zuo-Xiang LIU
Shan-Shan WU
Feng SUN
Basal insulin
Oral hypoglyce
m
ic agents
Type 2 diabetes
m
ellitus
Poor treat
m
ent effect
U
m
brella review
Details
Analysis of clinical features of tacrolimus induced acute pancreatitis based on literature cases
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1285-1295.
6622 times
2372 times
Chao YE
Xin LI
Li-Hua LIU
Xin HE
Shen-Jue CHEN
Juan WANG
Tacroli
m
us
Acute pancreatitis
Case report
Adverse drug reactions
Literature analysis
Details
National competent authority regulation and practice of drug benefit-risk communication in the United States, European Union and China
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(1):19-27.
9309 times
2297 times
ZHANG Yinan
WU Tingxi
ZHAO Zhigang
Drug benefit-risk co
m
m
unication
Safety co
m
m
unication
Drug safety infor
m
ation
Phar
m
acovigilance
Details
A case of severe immune-related ulcerative colitis caused by pembrolizumab
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1311-1315.
8445 times
1783 times
Jin-Jin ZOU
Ji-Liang ZHANG
Ni LI
Ding-Yi LIU
Pe
m
brolizu
m
ab
Lung squa
m
ous cell carcino
m
a
Severe i
m
m
une-related ulcerative colitis
Adverse drug reactions
Details
Pharmaceutical practice of clinical pharmacists participating in the treatment for refractory edema secondary to diabetic kidney disease
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(12):1425-1431.
8342 times
2086 times
Ze CHEN
Wei TIAN
Qi JIN
Xian-Xi GUO
Hua HU
Clinical phar
m
acist
Drug treat
m
ent
Diabetic kidney disease
Refractory ede
m
a
Phar
m
aceutical care
Details
Literature case analysis of hyperammonemic encephalopathy caused by sodium valproate
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(12):1417-1424.
8459 times
1625 times
Li-Yuan WANG
Jing LI
Zi-Hao DUAN
Fa-Cai WANG
Jun-Jie JIANG
Sodiu
m
valproate
Hypera
m
m
one
m
ic encephalopathy
Adverse drug reactions
Case analysis
Details
Cost-utility analysis of azacitidine versus decitabine in the treatment of myelodysplastic syndrome
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(12):1371-1379.
8825 times
1828 times
La-Ji DANZENG
Yong-Gong YANG
Si-Liang WANG
Meng-Ying LIU
Azacitidine
Decitabine
M
yelodysplastic syndro
m
e
M
arkov
m
odel
Cost-utility analysis
Phar
m
acoecono
m
ics
Details
Review and risk information management of neuropathy induced by emerging anti-tumor drugs
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(1):9-18.
9483 times
1823 times
LYU Feng
SONG Wei
XIN Mengru
XIE Di
ZHANG Wenqing
HE Wen
HU Hankun
E
m
erging anti-tu
m
or drugs
Drug-induced neuropathy
Drug risk infor
m
ation
m
anage
m
ent
Details
Case analysis of abnormal increase in blood glucose after targeted combination chemotherapy in a patient with colon cancer
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(2):230-235.
9129 times
2711 times
WU Yan
WANG Xin
Diabetic ketoacidosis
High blood sugar
Fluorouracil
Bevacizu
m
ab
Details
上一页
1
2
31
32
33
34
35
36
37
135
136
下一页
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University